Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care

Annals of Internal Medicine

Volumn 169, Issue 5, 2018, Pages 300-310

  O’Brien, Rebecca ^a   Johnson, Eric ^a   Haneuse, Sebastien ^b   Coleman, Karen J ^a   O’Connor, Patrick J ^c   Fisher, David P ^d   Sidney, Stephen ^e   Bogart, Andy ^f   Theis, Mary Kay ^a   Anau, Jane ^a   Schroeder, Emily B ^a   Arterburn, David ^a  

^a KAISER PERMANENTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

^e DIVISION OF RESEARCH   (United States)

^f RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC COMPLICATION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; DYSLIPIDEMIA; ELECTRONIC HEALTH RECORD; FEMALE; FOLLOW UP; GASTRIC BANDING; GASTRIC BYPASS SURGERY; GLYCEMIC CONTROL; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEVE GASTRECTOMY; SMOKING; UNITED STATES; CLINICAL TRIAL; COMPLICATION; DIABETIC ANGIOPATHY; INCIDENCE; MICROCIRCULATION; MORBID OBESITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MICROCIRCULATION; MIDDLE AGED; OBESITY, MORBID; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 85052874194     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-2383     Document Type: Article

References (57)

1. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-56. [PMID: 19272486] doi:10.1016/j.amjmed.2008.09.041
2. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-85. [PMID: 22449317] doi:10.1056/NEJMoa1200111
3. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-23. [PMID: 18212316] doi:10.1001/jama.299.3.316
4. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017; 376:641-51. [PMID: 28199805] doi:10.1056/NEJMoa1600869
5. Cummings DE, Arterburn DE, Westbrook EO, Kuzma JN, Stewart SD, Chan CP, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59:945-53. [PMID: 26983924] doi:10.1007/s00125-016-3903-x
6. Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150:931-40. [PMID: 26132586] doi:10.1001/jamasurg.2015.1534
7. Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billing-ton CJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlip-idemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309:2240-9. [PMID: 23736733] doi:10.1001/jama.2013.5835
8. Hutter MM, Schirmer BD, Jones DB, Ko CY, Cohen ME, Merkow RP, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254:410-20. [PMID: 21865942] doi:10.1097 /SLA.0b013e31822c9dac
9. Zellmer JD, Mathiason MA, Kallies KJ, Kothari SN. Is laparoscopic sleeve gastrectomy a lower risk bariatric procedure compared with laparoscopic Roux-en-Y gastric bypass? A meta-analysis. Am J Surg. 2014;208:903-10. [PMID: 25435298] doi:10.1016/j.amjsurg.2014 .08.002
10. Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. 2016;316:602-10. [PMID: 27532915] doi:10.1001/jama.2016.10924
11. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649-56. [PMID: 20699456] doi:10.1001 /jama.2010.1111
12. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43: 817-24. [PMID: 8469345]
13. Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med. 2016;164:542-52. [PMID: 26928912] doi:10.7326/M15 -3016
14. Coleman KJ, Haneuse S, Johnson E, Bogart A, Fisher D, O’Connor PJ, et al. Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery. Diabetes Care. 2016;39:1400-7. [PMID: 27271192] doi:10.2337/dc16-0194
15. Adams TD, Arterburn DE, Nathan DM, Eckel RH. Clinical outcomes of metabolic surgery: microvascular and macrovascular complications. Diabetes Care. 2016;39:912-23. [PMID: 27222549] doi: 10.2337/dc16-0157
16. Carlsson LMS, Sjöholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, et al. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol. 2017;5:271-9. [PMID: 28237791] doi:10.1016 /S2213-8587(17)30061-X
17. Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279-89. [PMID: 28405878] doi:10.1007/s11695-017-2666-x
18. Ross TR, Ng D, Brown JS, Pardee R, Hornbrook MC, Hart G, et al. The HMO research network virtual data warehouse: a public data model to support collaboration. EGEMS (Wash DC). 2014;2:1049. [PMID: 25848584] doi:10.13063/2327-9214.1049
19. Arterburn D, Bogart A, Coleman KJ, Haneuse S, Selby JV, Sherwood NE, et al. Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013;7:e258-68. [PMID: 24306153] doi:10.1016/j.orcp.2012.08.196
20. Arterburn DE, Bogart A, Sherwood NE, Sidney S, Coleman KJ, Haneuse S, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013;23:93-102. [PMID: 23161525] doi:10.1007/s11695 -012-0802-1
21. Mahalanobis PC. On the generalized distance in statistics. Proceedings of the National Institute of Science of India. 1936;2:49-55.
22. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al; Chronic Kidney Disease Prognosis Consortium. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307:1941-51. [PMID: 22570462] doi:10.1001/jama.2012.3954
23. Harrell FE. Regression Modeling Strategies. Secaucus, NJ: Springer-Verlag; 2006.
24. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol. 2001;27:85-95.
25. VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268-74. [PMID: 28693043] doi:10.7326/M16-2607
26. Still CD, Wood GC, Benotti P, Petrick AT, Gabrielsen J, Strodel WE, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 2014;2:38-45. [PMID: 24579062]
27. Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297-304. [PMID: 24915261] doi:10.1001/jama.2014.5988
28. Carlsson LM, Romeo S, Jacobson P, Burza MA, Maglio C, Sjöholm K, et al. The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial. Int J Obes (Lond). 2015;39:169-75. [PMID: 24798033] doi:10.1038/ijo.2014.72
29. Johnson BL, Blackhurst DW, Latham BB, Cull DL, Bour ES, Oliver TL, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216:545-56. [PMID: 23391591] doi:10.1016/j.jamcollsurg.2012 .12.019
30. Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg. 2010;20:308-15. [PMID: 20217955] doi:10.1007/s11695 -009-0026-1
31. Alexander JW, Goodman HR, Hawver LR, Cardi MA. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis. 2009;5:237-41. [PMID: 18996757] doi:10 .1016/j.soard.2008.08.016
32. Fenske WK, Dubb S, Bueter M, Seyfried F, Patel K, Tam FW, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9:559-68. [PMID: 22608055] doi:10 .1016/j.soard.2012.03.009
33. Navarro-Díaz M, Serra A, Romero R, Bonet J, Bayés B, Homs M, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17:S213-7. [PMID: 17130264]
34. Schuster DP, Teodorescu M, Mikami D, Foreman K, Rogers P, Needleman BJ. Effect of bariatric surgery on normal and abnormal renal function. Surg Obes Relat Dis. 2011;7:459-64. [PMID: 21273140] doi:10.1016/j.soard.2010.11.015
35. Imam TH, Fischer H, Jing B, Burchette R, Henry S, DeRose SF, et al. Estimated GFR before and after bariatric surgery in CKD. Am J Kidney Dis. 2017;69:380-8. [PMID: 27927587] doi:10.1053 /j.ajkd.2016.09.020
36. Li K, Zou J, Ye Z, Di J, Han X, Zhang H, et al. Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis. PLoS One. 2016;11:e0163907. [PMID: 27701452] doi:10.1371/journal.pone.0163907
37. Miras AD, Chuah LL, Khalil N, Nicotra A, Vusirikala A, Baqai N, et al. Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study. Diabetologia. 2015;58:1443-7. [PMID: 25893730] doi:10.1007/s00125-015 -3595-7
38. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837-53. [PMID: 9742976]
39. Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, et al; ACCORD Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363:233-44. [PMID: 20587587] doi:10.1056/NEJMoa1001288
40. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360: 129-39. [PMID: 19092145] doi:10.1056/NEJMoa0808431
41. Thomas RL, Prior SL, Barry JD, Luzio SD, Eyre N, Caplin S, et al. Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. J Diabetes Complications. 2014;28:191-5. [PMID: 24332764] doi: 10.1016/j.jdiacomp.2013.10.006
42. Varadhan L, Humphreys T, Walker AB, Cheruvu CV, Varughese GI. Bariatric surgery and diabetic retinopathy: a pilot analysis [Letter]. Obes Surg. 2012;22:515-6. [PMID: 22246396] doi:10.1007/s11695 -012-0600-9
43. Kim YJ, Seo du R, Kim MJ, Lee SJ, Hur KY, Choi KS. Clinical course of diabetic retinopathy in Korean type 2 diabetes after bariatric surgery: a pilot study. Retina. 2015;35:935-43. [PMID: 25574784] doi:10.1097/IAE.0000000000000412
44. Chen Y, Laybourne JP, Sandinha MT, de Alwis NMW, Avery P, Steel DH; Medscape. Does bariatric surgery prevent progression of diabetic retinopathy? Eye (Lond). 2017;31:1131-9. [PMID: 28731054] doi:10.1038/eye.2017.119
45. Morén Å, Sundbom M, Ottosson J, Granstam E. Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy. Acta Ophthalmol. 2018;96:279-82. [PMID: 28857463] doi:10.1111/aos.13555
46. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998;116:874-86. [PMID: 9682700]
47. Jackson S, le Roux CW, Docherty NG. Bariatric surgery and microvascular complications of type 2 diabetes mellitus. Curr Athero-scler Rep. 2014;16:453. [PMID: 25239035] doi:10.1007/s11883x -014-0453-x
48. Simó R, Hernández C. Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate. Rev Recent Clin Trials. 2012;7:71-80. [PMID: 21864248]
49. Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, et al; DIRECT Programme Study Group. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet. 2008; 372:1385-93. [PMID: 18823658] doi:10.1016/S0140-6736(08)61411 -7
50. Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care. 1995;18:631-7. [PMID: 8586000]
51. Renner AB, Dietrich-Ntoukas T, Jägle H. Recurrent episodes of night blindness in a patient with short bowel syndrome. Doc Ophthalmol. 2015;131:221-30. [PMID: 26507840] doi:10.1007/s10633 -015-9516-8
52. Singer JR, Bakall B, Gordon GM, Reddy RK. Treatment of vitamin A deficiency retinopathy with sublingual vitamin A palmitate. Doc Ophthalmol. 2016;132:137-45. [PMID: 26980447] doi:10.1007 /s10633-016-9533-2
53. Saenz-de-Viteri M, Sádaba LM. Optical coherence tomography assessment before and after vitamin supplementation in a patient with vitamin A deficiency: a case report and literature review. Medicine (Baltimore). 2016;95:e2680. [PMID: 26871796] doi:10.1097 /MD.0000000000002680
54. Rapoport Y, Lavin PJ. Nutritional optic neuropathy caused by copper deficiency after bariatric surgery. J Neuro-ophthalmol. 2016;36:178-81. [PMID: 26828841] doi:10.1097/WNO .0000000000000333
55. Sawicka-Pierko A, Obuchowska I, Hady RH, Mariak Z, Dadan J. Nutritional optic neuropathy following bariatric surgery. Wideochir Inne Tech Maloinwazyjne. 2014;9:662-6. [PMID: 25562012] doi: 10.5114/wiitm.2014.47262
56. Weinstein AL, Marascalchi BJ, Spiegel MA, Saunders JK, Fager-lin A, Parikh M. Patient preferences and bariatric surgery procedure selection; the need for shared decision-making. Obes Surg. 2014; 24:1933-9. [PMID: 24788395] doi:10.1007/s11695-014-1270-6
57. Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961. [PMID: 25164369] doi:10.1136/bmj.g3961